Avery Dennison Corp. (0HJR)
London Exchange · UK · prices in USD · close of 22 Oct 2026
Key indicators
| Last close | USD 182.88 |
|---|---|
| 52-week range | 148.15 – 199.11 |
| Return, 1 month / 3 months | +7.2% / +17.2% |
| Return, 1 year / 3 years | +4.9% / +10.9% |
| Trend | Uptrend |
| RSI (14) | 72 |
| Volatility (1 year) | 24.7% |
| Worst drawdown (1 year) | -21.5% |
| Average daily value traded | 0.06M USD |
| Dividend yield | 2.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Avery Dennison is a materials science and manufacturing company based in California. It makes pressure-sensitive adhesive materials, label and packaging solutions, and RFID inlays and tags used for item-level tracking. Its customers include consumer goods makers, retailers, logistics operators and industrial manufacturers, who use its products for labelling, branding, packaging and supply-chain identification. The company also supplies graphics and reflective materials for vehicles and signage.
On this site Avery Dennison Corp. appears as a stock on the London Exchange (UK), code 0HJR, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Avery Dennison Corp. (0HJR) trades on the London Exchange in UK. It last closed at USD 182.88 on 22 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 1,231 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 4.9% and over the last three months it rose 17.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 67 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 7.0% | ||
| From 52-week high | -7.2% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 17.2% | ||
| 6-month return | 11.0% | ||
| 12-month return, skipping the last month | -2.1% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 24.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.5% | ||
| Liquidity | 26 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.06M USD | ||
| Zero-volume days | 1.7% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.1% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.3% |
|---|---|
| 1 month | +7.2% |
| 3 months | +17.2% |
| 6 months | +11.0% |
| 1 year | +4.9% |
| 3 years | +10.9% |
| 5 years | −6.7% |
Signals
| 50-day / 200-day average | 173.89 / 170.88 |
|---|---|
| Golden / death cross (60 days) | Golden, 20 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.20 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Sep 2026 | USD 1.0000 |
| 3 Jun 2026 | USD 1.0000 |
| 3 Mar 2026 | USD 0.9400 |
| 2 Dec 2025 | USD 0.9400 |
| 3 Sep 2025 | USD 0.9400 |
| 3 Jun 2025 | USD 0.9400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.